Product Program year 2021 Source: CMS Open Payments

BD OptiBuild

Device Cell Analysis

PDI 00382906623867

Open in the dashboard

General payments

$85,413

25 payments

Research payments

$0

0 payments

Through program year 2021, $85,413 in general payments and $0 in research payments were reported against BD OptiBuild (Cell Analysis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $85,413 25

Breakdown

Who paid General payments · program year 2021
  1. Becton, Dickinson and Company $85,413 25 payments
Top recipients General payments · program year 2021
  1. Dana-Farber Cancer Institute Teaching hospital · MA $58,453 68% · 10 payments
  2. John Pesando Hematology & Oncology · Seattle, WA $22,629 26% · 4 payments
  3. Brigham And Womens Hospital Teaching hospital · MA $1,951 2% · 1 payment
  4. Ut Md Anderson Cancer Center Teaching hospital · TX $1,080 1% · 1 payment
  5. David Sachs Clinical & Laboratory Immunology · Boston, MA $748 <1% · 2 payments

The top 5 of 9 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Hematology & Oncology Internal Medicine $22,629 97% · 1 practitioner
  2. Clinical & Laboratory Immunology Allergy & Immunology $748 3% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. Massachusetts $61,348 72% · 5 recipients
  2. Washington $22,629 26% · 1 recipient
  3. Texas $1,080 1% · 1 recipient
  4. Colorado $188 <1% · 1 recipient
  5. Illinois $168 <1% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

25 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record